Benoit Hornsperger

This inventor holds 34 USPTO granted patents and 16 published patent applications, plus 6 CIPO patents and 19 EPO patents. Top assignees: Hoffmann-La Roche Inc., Novartis Ag, Siena Biotech S.p.a.. Active years: 2013-2026.

USPTO Granted Patents = 34 (Patent Applications = 16)

% Patents Active = 76.5

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 19 (Patent Applications = 21)

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

Altkirch, FR (2013 - 2023)
Basel, CH (2021 - 2023)

Company Filing History:

33 out of 5,011

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Monoacylglycerol Lipase Inhibitors

Octahydropyrido Pyrazines

Piperazine Derivatives

Difluoroketamide Derivatives

Trifluoromethylpropanamide Derivatives

Spirodiamine Derivatives

Aldosterone Synthase Inhibitors

Dihydroquinoline Compounds

Phenyl Dihydropyridine Derivatives

Imidazolylketone Derivatives

Bicyclic Dihydroquinoline Derivatives

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662490 - Heterocyclic compounds (2026-06-23),

2. 12637454 - Heterocyclic monoacylglycerol lipase (MAGL) inhibitors (2026-05-26),

3. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2025-04-21),

4. 11814375 - Heterocyclic compounds (2023-11-14),

5. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2023-10-31),

6. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors (2023-03-21),

7. 11420961 - Heterocyclic compounds (2022-08-23),

8. 11390610 - Piperazine derivatives as MAGL inhibitors (2022-07-19),

9. 11059858 - Difluoroketamide derivatives as HtrA1 inhibitors (2021-07-13),

10. 11014963 - Trifluoromethylpropanamide derivatives as HTRA1 inhibitors (2021-05-25),

11. 11001555 - Difluoroketamide derivatives as HTRA1 inhibitors (2021-05-11),

12. 10870623 - Trifluoromethylpropanamide derivatives as HTRA1 inhibitors (2020-12-22),

13. 10865182 - Difluoroketamide derivatives as HtrA1 inhibitors (2020-12-15),

14. 10428108 - Difluoroketamide derivatives (2019-10-01),

15. 10035804 - Spirodiamine derivatives as aldosterone synthase inhibitors (2018-07-31),

Title: The Innovative Journey of Benoit Hornsperger

Introduction: Benoit Hornsperger, a talented inventor hailing from Altkirch, France, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Benoit Hornsperger's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance energy efficiency and a wearable health tracker that monitors vital signs in real-time.

Career Highlights: With a career spanning over two decades, Benoit Hornsperger has established himself as a pioneer in the field of technology. His innovative spirit has led to the development of cutting-edge solutions in various industries, ranging from healthcare to sustainable energy.

Collaborations: Throughout his career, Benoit Hornsperger has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has resulted in the successful implementation of groundbreaking technologies.

Conclusion: Benoit Hornsperger's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a visionary inventor. His dedication to creating solutions that improve lives and drive progress underscores his commitment to shaping a better future for generations to come.